SCHEMBL4065253

SCHEMBL4065253

Cc1cc(Br)ccc1S

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5424955 0.79 — —
SCHEMBL29767277 0.75 — —
SCHEMBL330857 0.75 — —
SCHEMBL30141068 0.75 — —
SCHEMBL6345744 0.75 — —
SCHEMBL40336 0.75 — —
SCHEMBL29419590 0.75 — —
SCHEMBL1695904 0.72 ALDH1A1 (0.48) —
SCHEMBL29511362 0.72 — —
SCHEMBL234687 0.72 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 45 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-102603733-A 3, 8-bis-(5-methyl-2-thienyl)-1, 10-phenanthroline, preparation method thereof and application in zinc ion fluorescent sensing and cell imaging NANJING UNIVERSITY OF TECHNOLOGY 2012-07-25 — — CN claimed
US-11780819-B2 Aromatic substituted alkane-core monomers and polymers thereof for volume Bragg gratings META PLATFORMS TECHNOLOGIES, LLC (US) 2023-10-10 — — US disclosed
CN-115916756-A Sulfone derivative 豪夫迈·罗氏有限公司 2023-04-04 — — CN disclosed
US-9826741-B2 Tetrazolinone compound and application thereof SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2017-11-28 — — US disclosed
EP-2997613-B1 REDOX FLOW CELL FOR STORING ELECTRICAL ENERGY AND USE THEREOF Jenabatteries GmbH (DE) 2017-11-22 — — EP disclosed
US-9822095-B2 Tetrazolinone compound and application thereof SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2017-11-21 — — US disclosed
US-9822095-B2 Tetrazolinone compound and application thereof SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2017-11-21 — — US disclosed
US-20170107196-A1 TETRAZOLINONE COMPOUND AND APPLICATION THEREOF SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2017-04-20 — — US disclosed
US-20170107196-A1 TETRAZOLINONE COMPOUND AND APPLICATION THEREOF SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2017-04-20 — — US disclosed
US-20170105415-A1 TETRAZOLINONE COMPOUND AND APPLICATION THEREOF SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2017-04-20 — — US disclosed
US-20040082779-A1 Melanocortin-4 receptor binding compounds and methods of use thereof MILLENNIUM PHARMACEUTICALS, INC. 2004-04-29 — — US disclosed
US-20030187023-A1 Sulfone derivatives, process for their production and use thereof TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2003-10-02 — — US disclosed
EP-1302462-A1 SULFONE DERIVATIVES, PROCESS FOR THEIR PRODUCTION AND USE THEREOF Takeda Chemical Industries, Ltd. (JP) 2003-04-16 — — EP disclosed
CN-1365347-A Anthracene derivative and electroluminescent device using the same IDEMITSU KOSAN CO (JP) 2002-08-21 — — CN disclosed
CN-1252069-A 5,6, 7-trisubstituted-4-aminopyrido [2, 3-d ] pyrimidine compounds ABBOTT LAB (US) 2000-05-03 — — CN disclosed
CN-1234029-A Chromene-3-carboxylate derivative SHIONOGI & CO (JP) 1999-11-03 — — CN disclosed
US-5434173-A Administering to treat acne, psoriasis, eczema, dermatitis, and other skin disorders ALLERGAN, INC. (US) 1995-07-18 — — US disclosed
US-5391753-A Tumor inhibiting agents; useful for treating dermatological conditions and rheumatic illnesses ALLERGAN, INC. (US) 1995-02-21 — — US disclosed
EP-0626955-A1 HETEROARYL SUBSTITUTED PHENYLETHENYL COMPOUNDS HAVING RETINOID-LIKE BIOLOGICAL ACTIVITY ALLERGAN, INC. (US) 1994-12-07 — — EP disclosed
WO-1993016067-A1 HETEROARYL SUBSTITUTED PHENYLETHENYL COMPOUNDS HAVING RETINOID-LIKE BIOLOGICAL ACTIVITY ALLERGAN, INC. (US) 1993-08-19 — — WO disclosed
Send feedback